ResMed, Inc. engages in providing digital health and cloud-connected medical devices. Its digital health technologies and cloud-connected medical devices transform care for people with sleep apnea ...

Analysts on Wall Street project that ResMed (RMD) will announce quarterly earnings of $2.03 per share in its forthcoming report, representing an increase of 23.8% year over year. Revenues are ...

ResMed (RMD) could be a solid choice for investors given its recent upgrade to a Zacks Rank #2 (Buy). This upgrade is essentially a reflection of an upward trend in earnings estimates -- one of the ...

Bank of America Securities analyst Lyanne Harrison has reiterated their bullish stance on RMD stock, giving a Buy rating on October 10. Lyanne ...

2030 ambition to help more than 500 million people worldwide achieve their full health potential Showcases integration of intelligent products and solutions within the ResMed ecosystem ...

Valued at $35.3 billion by market cap, San Diego, California-based ResMed Inc. (RMD) develops, manufactures, distributes, and markets medical devices and cloud-based software applications for ...

NEW YORK — The morning after presenting an upbeat outlook to analysts in a gilded hall in the New York Stock Exchange building, Mick Farrell, the CEO of ResMed, looked refreshed, despite a post ...

Shares of ResMed Inc. RMD sank 0.35% to $238.34 Wednesday, on what proved to be an all-around positive trading session for ...

Shares of ResMed Inc. RMD inched 0.17% higher to $240.00 Friday, on what proved to be an all-around great trading session for ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...